ITW vs RCUS · P/E 22, rev $16.04B vs rev $258.0M
Illinois Tool Works Inc (ITW) versus Arcus Biosciences Inc (RCUS) — a side-by-side from cached financials, not a winner call.
Illinois Tool Works Inc (ITW) is a specialty industrial machinery company listed on US.
Arcus Biosciences Inc (RCUS) is a biotechnology company listed on US.
Latest reported ITW revenue for 2025-12-31 was $16.04B. Net income was $3.07B. Revenue was up 0.9% from 2024-12-31 to 2025-12-31. ITW currently screens at market cap $72.53B and trailing P/E 21.8.
Latest reported RCUS revenue for 2024-12-31 was $258.0M. Net income was -$283.0M. Revenue was up 120.5% from 2023-12-31 to 2024-12-31. RCUS currently screens at market cap $885.2M.
ITW currently screens at market cap $72.53B and trailing P/E 21.8. RCUS currently screens at market cap $885.2M.
Not investment advice. Open the ITW and RCUS stock pages for the full models.
Not investment advice.